Age of donor alters the effect of cyclic hydrostatic pressure on production by human macrophages and osteoblasts of sRANKL, OPG and RANK
© Evans et al; licensee BioMed Central Ltd. 2006
Received: 11 July 2005
Accepted: 06 March 2006
Published: 06 March 2006
Cyclic hydrostatic pressure within bone has been proposed both as a stimulus of aseptic implant loosening and associated bone resorption and of bone formation. We showed previously that cyclical hydrostatic pressure influenced macrophage synthesis of several factors linked to osteoclastogenesis. The osteoprotegerin/soluble receptor activator of NF-kappa β ligand /receptor activator of NF-kappa β (OPG/ RANKL/ RANK) triumvirate has been implicated in control of bone resorption under various circumstances. We studied whether cyclical pressure might affect bone turnover via effects on OPG/ sRANKL/ RANK.
In this study, cultures of human osteoblasts or macrophages (supplemented with osteoclastogenic factors) or co-cultures of macrophages and osteoblasts (from the same donor), were subjected to cyclic hydrostatic pressure. Secretion of OPG and sRANKL was assayed in the culture media and the cells were stained for RANK and osteoclast markers. Data were analysed by nonparametric statistics.
In co-cultures of macrophages and osteoblasts, pressure modulated secretion of sRANKL or OPG in a variable manner. Examination of the OPG:sRANKL ratio in co cultures without pressurisation showed that the ratio was greater in donors <70 years at the time of operation (p < 0.05 Mann Whitney U) than it was in patients >70 years. However, with pressure the difference in the OPG:sRANKL ratios between young and old donors was not significant. It was striking that in some patients the OPG:sRANKL ratio increased with pressure whereas in some it decreased. The tendency was for the ratio to decrease with pressure in patients younger than 70 years, and increase in patients ≥ 70 years (Fishers exact p < 0.01).
Cultures of osteoblasts alone showed a significant increase in both sRANKL and OPG with pressure, and again there was a decrease in the ratio of OPG:RANKL. Secretion of sRANKL by cultures of macrophages alone was not modulated by pressure. Only sRANKL was assayed in this study, but transmembrane RANKL may also be important in this system. Macrophages subjected to pressure (both alone and in co-culture) stained more strongly for RANK on immunohistochemstry than non-pressurized controls and 1,25-dihydroxyvitamin D3 (1,25 D3) further increased this. Immunocytochemical staining also demonstrated that more cells in pressurized co-cultures exhibited osteoclast markers (tartrate-resistant acid phosphatase, vitronectin receptor and multinuclearity) than did unpressurized controls.
These data show that in co-cultures of osteoblasts and macrophages the ratio of OPG : sRANKL was decreased by pressure in younger patients but increased in older patients. As falls in this ratio promote bone resorption, this finding may be important in explaining the relatively high incidence of osteolysis around orthopaedic implants in young patients. The finding that secretion of OPG and sRANKL by osteoblasts in monoculture was sensitive to hydrostatic pressure, and that hydrostatic pressure stimulated the differentiation of macrophages into cells exhibiting osteoclast markers indicates that both osteoblasts and preosteoclasts are sensitive to cyclic pressure. However, the effects of pressure on cocultures were not simply additive and coculture appears useful to examine the interaction of these cell types.
These findings have implications for future therapies for aseptic loosening and for the development of tests to predict the development of this condition.
The effect of strain on bone is now well documented [1–3] and it is clear that increased strain generally leads to increased bone formation. A few studies have examined the effect of hydrostatic compression on bone or bone cells [4–10] and similarly found that hydrostatic compression is likely to lead to increased net bone formation. Both cancellous and cortical bone has a structure of multiple interconnected spaces and there is evidence that applied strain leads to changes in intraosseous pressure. It is possible that, biologically speaking, cyclic hydrostatic pressure may be more influential than strain in a dense structural tissue such as bone.
Aseptic loosening and associated bone loss is the commonest complication of orthopaedic implants. Most studies have concentrated on the role of wear particles and the subsequent invasion of the joint space by activated macrophages . Research has shown that elevated hydrostatic pressures develop in aseptic loosening and there is increasing evidence that this may contribute to loosening and macrophage activation [12–18]. The activated macrophages are responsible for the increased bone resorption seen in aseptic loosening, and several studies have demonstrated that they are able to differentiate into osteoclasts [19–22]. There has been debate about whether, in vivo, macrophage rich membranes are responsible for bone resorption per se, or whether this is only performed by osteoclasts which are in turn activated by products of the macrophage. The actual importance of this distinction for possible treatment of aseptic loosening is unclear.
Previous studies in our laboratory demonstrated that cyclical hydrostatic pressure increased macrophage synthesis of several cytokines [23, 24], of macrophage-colony stimulating factor (M-CSF), chemokines and prostaglandin E2 . These molecules are known to be important in bone resorption and turnover and in osteoclastogenesis, but the mechanisms by which they exert their effects in vivo (especially in relation to implant loosening) are still poorly understood. In addition, we have shown that cyclical hydrostatic pressure increased macrophage-mediated bone resorption in bone organ cultures .
The three molecules, RANK, RANKL and OPG, have now been shown to be pivotal to bone homeostasis . They are intimately involved in osteoclastogenesis [27–30] and studies have shown that alterations to the ratio of OPG:RANKL affect bone turnover [31–33]. We therefore examined the effect of cyclical hydrostatic pressure on secretion of OPG, RANKL and RANK by human macrophages and osteoblasts in vitro. In addition, as these molecules are important in the modulation of osteoclastogenesis, the effect of cyclical hydrostatic pressure on the phenotype of the macrophage was also investigated.
Co-cultures of macrophages and osteoblasts
For co-cultures, 50 mls of blood was taken from donor patients 6 weeks after primary hip replacement. Monocytes were isolated using Lymphoprep density gradient medium (Apogent Discoveries UK) as described previously . An average of 11.3 × 106 monocytes were isolated per sample. Briefly, peripheral blood mononuclear cells were suspended in Minimum Essential Medium (MEM) and placed in a tissue culture flask (Nunc) for one hour at 37°C with 5% CO2. Monocytes were separated from the rest of the cell population by adherence. After removal of non-adherent cells, the adherent cells were scraped off using a cell scraper and resuspended in culture medium (MEM, 20% foetal calf serum (FCS), 1% Penicillin / Streptomycin, 1% Glutamate). Cell numbers were counted and used in the experiments as described below.
Osteoblasts were isolated from human trabecular bone using the explant technique, as described previously  using bone samples removed during elective surgery for primary hip replacement. Osteoblasts were seeded onto slices of dentine (100 μm thick, 4.0 mm diameter), at 5 × 105 cells/ml (1 × 105 per slice) and placed in 96-well plates (Corning UK) before culturing overnight in Dulbecco's modified Eagles medium (DMEM, Invitrogen UK) supplemented with 20% foetal calf serum (FCS, Invitrogen UK). Human macrophages were then seeded onto the osteoblast layer at a density of 5 × 105 cells/ml (1 × 105 cells per slice) and the co-cultures were incubated for a further six days in DMEM supplemented with 20% foetal calf serum, 1% glutamine (Invitrogen UK), 30 ng/ml M-CSF, (R+D Systems UK), 10-8M Dexamethasone (Sigma UK) and 10-7M 1,25D3 (Sigma UK). Three replicate wells per treatment were set up for each experiment and both cell types were from the same donor. Informed consent was obtained from patients before samples were taken for this research, and the study was approved by the Salford LREC.
The co-cultures were subjected to 34.5 × 10-3MPa (5psi) cyclical hydrostatic pressure (2 secs on, 2 secs off) for one hour for 4 consecutive days in our unique pressurization apparatus , in a 5% CO2/balance air environment (B.O.C. Special Gases Ltd UK). Cultures were allowed to rest for 23 hours after pressurization before media were harvested for assay and stored at -20°C before assaying for OPG and sRANKL. Cells on the dentine were stained to determine cell type.
Culture of macrophages
Monocytes were prepared as above, from normal blood or blood from patients prior to primary hip replacement, prior to use in the following experiment.
Human macrophages were seeded onto slices of dentine at 5 × 105 cells/ml (1 × 105 cells per slice) before culturing for a further six days in DMEM supplemented with 20% FCS, 1% glutamine, 30 ng/ml M-CSF, 10-8M Dexamethasone and 10-7M 1,25D3. Three replicate wells per treatment were set up for each experiment.
The cultures were subjected to 34.5 × 10-3MPa (5psi) cyclical hydrostatic pressure (2 secs on, 2 secs off) for one hour for 4 consecutive days. Cultures were allowed to rest for 23 hours after pressurization before media were harvested for assay and stored at -20°C before assaying for OPG and sRANKL.
Culture of osteoblasts
Osteoblasts isolated for the co-cultures were also cultured without macrophages. Cells were seeded onto slices of dentine at a cell density of 5 × 105 cells/ml (1 × 105 per slice) and cultured as above for 6 days before subjecting them to pressure (see above). Cultures were allowed to rest for 23 hours after pressurization before media were harvested and stored at -20°C before assaying for OPG and sRANKL.
For all co-culture/macrophage/osteoblast experiments, control cultures (i.e. not subjected to hydrostatic pressure) were included.
Effect of hydrostatic pressure on OPG and sRANKL secretion
Culture media were assayed directly for sRANKL using a specific ELISA kit (Peprotech EC – human sRANKL ELISA development kit), according to the manufacturers directions. Culture media was assayed for OPG using an in-house ELISA method . A goat anti-human OPG antibody was used (R+D Systems UK) to coat the ELISA plates (Appleton Woods UK). The standard curve consisted of dilutions of recombinant human OPG (Alexis Corp.). A biotinylated goat anti-human OPG antibody (R+D Systems UK) was used with ExtraAvidin peroxidase (Sigma UK) to amplify the signal. OPG binding was visualised using TMB (Pierce Chemical Co.) and optical densities determined at 450 nm. Inter- and intra- assay variation was 12.8% and 7.7% respectively and specificity was confirmed by recovery experiments using heparin-affinity purified human OPG.
For all these experiments, control cultures (i.e. not subjected to hydrostatic pressure) were included.
Effect of 1,25 dihydroxyvitamin D3 on RANK production by macrophages
Monocytes were isolated as described previously  from normal blood or blood from patients prior to primary hip replacement. The macrophages thus obtained were cultured as before  prior to use in the experiments outlined below. Macrophages were cultured at 5 × 105/ml on Thermanox coverslips (Nunc, UK) in 24-well plates (Corning UK) and incubated in DMEM with 20% FCS and 1% glutamine, for 7 days. 1,25D3 was added to the cultures at either 10-7M or 10-9M one hour before cultures were pressurised at 34.5 × 10-3MPa (5.0 psi), (2 secs on, 2 secs off) for one hour . To examine whether the effect of pressure was additive, some cultures were subjected to one cycle of pressure (1 × 1 hour) and others to four cycles (the four cycles being performed on consecutive days). Cultures were allowed to rest for 23 hours after pressurization before macrophages were fixed in 100% ice-cold ethanol (BDH, UK) for two minutes.
Cell cultures were immunostained for RANK with a specific polyclonal antibody to RANK (Santa Cruz Biotechnology, USA; RANK C-20). Briefly, cells were incubated overnight at 4°C with anti-RANK (1/100) and positive staining disclosed using the ABC technique (Vectastain, UK). Control slides were incubated with 1% non-immune serum (Normal horse serum; Vectastain) to check antibody specificity. All slides were stained at the same time to minimise variation in staining intensity.
Effect of hydrostatic pressure on osteoclast markers
Monocytes were isolated as described previously  from the venous blood of healthy volunteers. The macrophages thus obtained were cultured as before  prior to use in the experiment outlined below. Macrophages were cultured at 5 × 105/ml on Thermanox coverslips (Nunc, UK) in 24-well plates and incubated in DMEM, 20% FCS, 1% Glutamine, supplemented with 30 ng/ml M-CSF, 10-8M Dexamethasone, 30 ng/ml sRANKL and 10-7M 1,25D3, for 7 days. Cultures were then subjected to hydrostatic pressure at 34.5 × 10-3MPa (5.0 psi) (2 secs on, 2 secs off) for one hour.
To examine whether the effect of pressure was additive, cultures were subjected to either one or four cycles of pressure (the four cycles being performed on consecutive days). Cultures were allowed to rest for 23 hours after pressurization before media were harvested and frozen at -20°C. Macrophages were fixed in 100% ice-cold ethanol (BDH, UK) for 2 minutes and stored at -20°C.
Cells were stained for tartrate-resistant acid phosphatase (TRAP) using a commercial kit (Sigma Cat. No.387-A), to demonstrate enzyme activity and multinuclearity. Cells were also immunostained for the vitronectin receptor (VNR) with a specific monoclonal antibody to VNR (Serotech; Cat. No MCA7576). Briefly, cells were incubated overnight at 4°C with anti-VNR (1/100) and positive staining disclosed using the ABC technique (Vectastain, UK). Control slides were incubated with 1% non-immune serum (Normal horse serum; Vectastain) to check antibody specificity.
For all these experiments, control cultures (i.e. not subjected to hydrostatic pressure) of cells from the same population were included.
Statistical analysis was performed on the data, where relevant. To demonstrate the effect of pressure, Friedmanns non-parametric two-way ANOVA followed by the Wilcoxon Signed Ranks Test was used. To demonstrate significance between different age groups, Mann Whitney U and Fishers Exact Test was used.
Effect of hydrostatic pressure on OPG and sRANKL secretion
Effect on co-cultures of macrophages and osteoblasts:
The effect of pressure on secretion of sRANKL and OPG by macrophages and osteoblasts cultured alone or in co-culture
Co-cultures of MP & OB
672 ± 180
703 ± 118
264 ± 39
878 ± 193
421 ± 61
270 ± 45
9.7 ± 2.7
23.6 ± 4.2
8.1 ± 1.75
12.5 ± 4.3
The effect of pressure on ratio of OPG : sRANKLis influenced by the age of the donor
OPG: sRANKL - P
OPG: sRANKL + P
+ P : - P
Effects on monocultures of osteoblasts:
For osteoblasts (from the same cell population) cultured without macrophages, pressure modulated secretion of both sRANKL and OPG. Pressure increased secretion of sRANKL by 73% and this increase was statistically significant (p = 0.002) (Wilcoxon Signed Ranks test); OPG secretion was increased by 89% and this increase was statistically significant (p = 0.034) (Wilcoxon Signed Ranks test) (Table 1). No change in the ratio of OPG:sRANKL was detected with pressure (65.2 ± 69.2 [no pressure] and 43.7 ± 42.6 [with pressure]).
Effects on monocultures of macrophages:
Pressure had no effect on secretion of sRANKL by macrophages cultured without osteoblasts (Table 1) (p = 0.69) (Wilcoxon Signed Ranks test) and OPG was not detectable in most of these cultures.
It was noticeable that basal secretion of sRANKL in the monocultures was substantially reduced and that basal secretion of OPG increased, compared with the co-cultures (Table 1). The application of pressure to the cultures increased the total secretion of sRANKL in the osteoblast monocultures to that seen in the co-cultures, but this was not seen in the macrophage monocultures. It is notable that pressure increased total OPG secretion by monocultures of osteoblasts to above that seen in the pressurized co-cultures (Table 1).
Effect of hydrostatic pressure on RANK in macrophage cultures
The intensity of the RANK immunostaining was semi-quantified by grading from a score of no positively stained cells (-), some positively stained cells (+/-), to all cells positively and densely stained (+++) (Table 3.).
Effect of hydrostatic pressure on OC markers
Three molecules, OPG, RANKL and RANK, play a vital role in controlling bone homeostasis . Osteoclastogenesis is initiated and maintained by at least two key factors produced locally in bone, M-CSF and RANKL. RANKL is found both as a transmembrane molecule on osteoblasts, which also secrete OPG, and as a secreted molecule, sRANKL. OPG opposes RANKL and blocks osteoclastogenesis. RANK is found on osteoclast-like cells and mononuclear cells in bone  and other tissues [36, 37]. The balance between OPG, RANKL and RANK is crucial to bone homeostasis  as the ratio between OPG and RANKL modulates osteoclast activity and has been shown to vary during bone turnover [31–33, 39]. Increases in OPG:RANKL would be expected to favour bone formation, and decreases to favour resorption.
To date, only a handful of studies have addressed the role of RANKL in aseptic loosening [40–42], whilst the importance of OPG has only recently been examined in this context . The response to mechanical load vis a vis RANKL and OPG is variable. Strain has been shown to increase expression of RANKL mRNA in rat periodontal ligaments in vivo . In vitro, strain had no effect on synthesis of RANKL protein by periodontal ligament cells  although OPG expression was increased . Bone stromal cells respond differently to strain, which decreased RANKL mRNA in one study  and increased it in another . To the authors' knowledge, no studies to date have examined the effect of hydrostatic pressure on OPG or sRANKL in macrophages or osteoblasts.
The results reported here demonstrate that in cocultures of osteoblasts and macrophages from the same donor patient, the OPG:sRANKL ratio is affected both by age and by cyclic pressure. Without pressure, young patients (<70 years at operation) had higher OPG:sRANKL ratios. The effect of pressure on this was different in young and old patients, with young patients tending to show a fall in OPG:sRANKL and older patients showing a rise. After application of pressure there was no longer a significant difference between patients above and below 70 years.
Other groups have found a correlation between age and changes in the ratio of RANKL:OPG . Most patient studies have demonstrated an increase in circulating OPG with age [48–51] together with a decrease in sRANKL [48, 51]. Conversely, an in vitro study using murine bone marrow cells co-cultured with pre-osteoclasts demonstrated that, although osteoclastogenesis increased with age, the levels of RANKL mRNA increased whilst mRNA for OPG decreased . It is of interest that several pathologies have been linked to alterations in OPG and RANKL. The ratio of RANKL:OPG was increased in bone from elderly fracture patients [53, 54] and low levels of RANKL have been suggested as a predictor of fracture . In addition, in patients with rheumatoid arthritis, RANKL polymorphisms were associated with an earlier age of disease onset .
The finding that the effect of pressure on OPG:sRANKL in cocultures was different in young and old patients was unexpected. Young patients, who would normally be expected to have a bone forming response to activity (and hence to changes in intraosseous pressure), proved to often have a fall of OPG:sRANKL with pressure. This may be because our co-culture setup has a high ratio of macrophages (osteoclast precursors) to osteoblasts. The differing secretion of the mediators in monoculture and co-culture strongly suggest that the relative numbers of macrophages and osteoblasts will influence the OPG:sRANKL ratio. The setup of the co-cultures was designed to model the bone/membrane interface of a loosening membrane, and it is likely that it does not correspond to a normal bone surface. The proportions of macrophages and osteoblasts are more similar to the loosening membrane situation than to the surface of a normal piece of bone. The change in the effect of cyclic pressure with age may help explain why results of hip replacements are consistently better in older people (Swedish Hip Register 2003). This has previously been attributed to reduction in levels of activity (and hence implant wear) with age, but our findings indicate that young patients may be biologically more susceptible to the development of osteolysis and bone resorption in this situation. This finding may have value in developing tests predictive of implant loosening in young patients.
In osteoblasts cultured alone, secretion of both sRANKL and OPG was significantly increased under pressure and the mean ratio of OPG:sRANKL was decreased 49% in osteoblast monoculture. Pressure had no effect on secretion of sRANKL by MP monoculture and these cells secreted no detectable OPG. There is a theoretical possibility that, in these cultures, complexes may form between OPG and sRANKL. Whilst we know that TRAIL and RANKL inhibit the OPG assay (personal communication) no data is available on binding to such complexes for the sRANKL assay kit.
Comparison between co cultures and monocultures of detectable product (sRANKL or OPG) and of the mean ratio of OPG:sRANKL suggests a feedback mechanism could be operating between these two cell types in vitro and that pressure modulates this cell-cell communication. Active osteoblastic activity has previously been reported at the bone surface adjacent to loosening membranes , and, as our data demonstrated that pressure affected the ratio between OPG and sRANKL it is tempting to speculate that a similar effect may be produced in the in vivo situation. This suggested scenario does not take into account the contribution of transmembrane RANKL, which, for technical reasons, was not assayed in this study.
In addition, immunostaining of MP for RANK showed a clear increase in RANK after pressurization, compared to controls. In addition, the effect of pressure on RANK synthesis was cumulative, as RANK synthesis was increased when the number of loading cycles was increased. It is of interest that RANK synthesis was also increased when MP were cultured with 1,25 D3 (a factor strongly implicated in bone resorption) , as we have shown that pressure increases synthesis of 1,25 D3 by MP . Other studies have also shown that 1,25 D3 increased RANK expression in MP . In addition, expression of RANK has been shown to be elevated in peri-implant tissue in aseptic loosening, aiding osteoclast differentiation  and, as RANK demonstrates a autoregulatory positive feedback system, this could further enhance osteoclast differentiation in this tissue .
Cyclical hydrostatic pressure also modulated other markers on monocultures of human MP, moving them towards an osteoclast-like phenotype. After exposure to five sets of cyclical pressure, the majority of cells were positive for both TRAP and VNR. To our knowledge, this is the first time that cyclical hydrostatic pressure has been shown to influence MP differentiation in isolated MP. Others  have demonstrated that static compression inhibited osteoclast formation, but these studies were done using mouse marrow, where a mixed cell population was present and therefore no direct comparison can be made.
Other stimuli linked to osteoclastogenesis (1,25 D3, RANKL or osteoblasts themselves) increased the number of positive cells for these markers, when compared to controls. Exposure to the additional stimulus of hydrostatic pressure further increased the numbers of positive cells. However, very few multinucleated cells were visible, indicating that cell fusion, the end-stage of osteoclast differentiation, was not stimulated by pressure over the time scale of these studies.
An age-related difference in the ratio of OPG:sRANKL was found in co-cultures of osteoblasts and macrophages and cyclic hydrostatic pressure modulated this ratio, causing a reduction in younger patients. In monocultures, pressure increased OPG:sRANKL secretion by osteoblasts and RANK synthesis by macrophages. The macrophage phenotype was also modulated, generating osteoclast-like cells. In summary, pressure modulates cell activity, disturbing homeostasis and favouring osteolysis; the balance of the system differs between young and old patients.
This project was funded by the British Orthopaedic Research Association (Wishbone Trust). The funding was made possible by Kirby Laing Foundation, The George Livanos Trust, The Eleanor Peel Charitable Trust, The PF Trust and The Garfield Weston Foundation. We are also grateful to Dr M Marshall of the Charles Salt and Agnes Hunt Research Centre, Oswestry, UK, for his advice on OPG and time in performing the OPG assays.
- Granet C, Guignandon A, Vico L, Alexandre C, Lafage-Proust M-H: MAP and src kinases control the induction of AP-1 members in response to changes in mechanical environment in osteoblastic cells. Cellular Signalling. 2002, 14: 679-88. 10.1016/S0898-6568(02)00008-6.View ArticlePubMedGoogle Scholar
- Kaspar D, Seidl W, Neidlinger-Wilke C, Beck A, Claes L, Ignatius A: Proliferation of human-derived osteoblast-like cells depends on the cycle number and frequency of uni-axial strain. J Biomech. 2002, 35: 873-880. 10.1016/S0021-9290(02)00058-1.View ArticlePubMedGoogle Scholar
- Skerry TM: Identification of novel signalling pathways during functional adaptation of the skeleton to mechanical loading: the role of glutamate as a paracrine signalling agent in the skeleton. J Bone Min Res. 1999, 17: 66-70. 10.1007/s007740050067.View ArticleGoogle Scholar
- Klein-Nulend J, Veldhuijzen JP, de Jong M, Burger EH: Increased bone formation and decreased bone resorption in fetal mouse calvaria as a result of intermittent compressive force in vitro. Bone Min. 1987, 2 (6): 441-8.Google Scholar
- Roelofsen J, Klein-Nulend J, Burger EH: Mechanical stimulation by intermittent hydrostatic compression promotes bone-specific gene expression in vitro. J Biomech. 1995, 28: 1493-503. 10.1016/0021-9290(95)00097-6.View ArticlePubMedGoogle Scholar
- Glantschnig H, Varga F, Rumpler M, Klaushofer K: Prostacyclin (PGI2): a potential mediator of c-fos expression induced by hydrostatic pressure in oreoblastic cells. J Clin Invest. 1996, 26: 544-8. 10.1046/j.1365-2362.1996.165312.x.View ArticleGoogle Scholar
- Nagatomi , Arulanandam BP, Metzger DW, Meunier A, Bizios R: Frequency- and duration-dependent effects of cyclic pressure on select bone cell functions. Tissue Eng. 2001, 7: 717-728. 10.1089/107632701753337672.View ArticlePubMedGoogle Scholar
- Nagatomi , Arulanandam BP, Metzger DW, Meunier A, Bizios R: Cyclic pressure affects osteoblast functions pertinent to osteogenesis. Ann Biomed Eng. 2003, 31: 917-923. 10.1114/1.1590663.View ArticlePubMedGoogle Scholar
- Takai E, Mauck RL, Hung CT, Guo XE: Osteocyte viability and regulation of osteoblast function in a 3D trabecular bone explant under dynamic hydrostatic pressure. J Bone Min Res. 2004, 19: 1403-10. 10.1359/JBMR.040516.View ArticleGoogle Scholar
- Tasevski V, Sorbetti JM, Chiu SS, Shrive NG, Hart DA: Influence of mechanical signals on gene expression in human MG-63 cells: evidence for a complex interplay between hydrostatic compression and vitamin D3 or TGFβ-1 on MMP-1 and MMP-3 mRNA levels. Biochem Cell Biol. 2005, 83: 96-107. 10.1139/o04-124.View ArticlePubMedGoogle Scholar
- McGee MA, Howie DW, Costi K, Haynes DR, Wildenaur CI, Pearcy MJ, McLean JD: Implant retrieval studies of the wear and loosening of prosthetic joints: a review. Wear. 2000, 241: 158-65. 10.1016/S0043-1648(00)00370-7.View ArticleGoogle Scholar
- Hendrix RW, Wixson RL, Rana NA, Rogers IF: Arthrography after Total Hip Arthroplasty; a Modified Technique used in the Diagnosis of Pain. Radiology. 1983, 148: 647-652.View ArticlePubMedGoogle Scholar
- Anthony PP, Gie GA, Howie CR, Ling RSM: Localised Endosteal Bone Lysis in Relation to the Femoral Components of Cemented Total Hip Arthroplasty. J Bone Joint Surg (Br). 1990, 72: 971-979.Google Scholar
- Robertsson O, Wingsterand H, Kesteris U, Jonsson K, Onnerfalt R: Intracapsular pressure and loosening of hip prostheses. Acta Orthop Scand. 1997, 68: 231-234.View ArticlePubMedGoogle Scholar
- Aspenberg P, Van der Vis H: Fluid pressure may cause periprosthetic osteolysis: particle are not the only thing. Acta Orthop Scand. 1998, 69: 1-View ArticlePubMedGoogle Scholar
- Skoglund B, Aspenberg P: PMMA particles and pressure – a study of the osteolytic properties of two agents proposed to cause prosthetic loosening. J Orthop Res. 2003, 21: 196-201. 10.1016/S0736-0266(02)00150-X.View ArticlePubMedGoogle Scholar
- Schmalzried TP, Guttmann D, Grecula M, Amstutz HC: The relationship between the design, position and articular wear of acetabular components inserted without cement and the development of pelvic osteolysis. J Bone Joint Surg Am. 1995, 77: 1290-1.Google Scholar
- Yuan X, Ryd L, Huiskes R: Wear particle diffusion and tissue differentiation in TKA implant fibrous interfaces. J Biomech. 2000, 33: 1279-86. 10.1016/S0021-9290(00)00072-5.View ArticlePubMedGoogle Scholar
- Matsuzaki K, Udagawa N, Takahashi N, Yamaguchi K, Yasuda H, Shima N, Morinaga T, Toyama Y, Yabe Y, Higashio K, Suda T: Osteoclast differentiation factor (ODF) induces osteoclast-like cell formation in human peripheral blood mononuclear cell cultures. Biochem Biophys Res Comm. 1998, 246: 199-204. 10.1006/bbrc.1998.8586.View ArticlePubMedGoogle Scholar
- Quinn JMW, Neale S, Fujikawa Y, McGee JOD, Athanasou NA: Human osteoclast formation from blood monocytes, peritoneal macrophages and bone marrow cells. Calcif Tiss Int. 1998, 62 (6): 527-31. 10.1007/s002239900473.View ArticleGoogle Scholar
- Haynes DR, Crotti TN, Potter AE, Loric M, Atkins GJ, Howie DW, Findlay DM: The osteoclastogenic molecules RANKL an RANK are associated with periprosthetic osteolysis. J Bone Joint Res. 2001, 83-B: 902-911. 10.1302/0301-620X.83B6.10905.View ArticleGoogle Scholar
- Lader C, Scopes J, Horton M, Flanagan AM: Generation of human osteoclasts in stromal cell-free and stromal cell-rich cultures: differences in osteoclasts CD11c/CD18 integrin expression. Br J Haematol. 2001, 112: 430-437. 10.1046/j.1365-2141.2001.02437.x.View ArticlePubMedGoogle Scholar
- Ferrier GM, McEvoy A, Evans CE, Andrew JG: The effect of cyclical pressure on human monocyte-derived macrophages in vitro. J Bone Joint Surg. 2000, 82-B: 755-9. 10.1302/0301-620X.82B5.9561.View ArticleGoogle Scholar
- McEvoy A, Jeyam M, Ferrier G, Evans CE, Andrew JG: Synergistic effect of particles and cyclic pressure on cytokine production in human monocyte/macrophages : Proposed role in periprosthetic osteolysis. Bone. 2002, 30/1: 171-177. 10.1016/S8756-3282(01)00658-5.Google Scholar
- Sampathkumar S, Evans CE, Andrew JG: Role of cyclical pressure in release of M-CSF, chemokines and PGE2 and their role in implant loosening. J Bone Joint Surg. 2003, 85-B (2): 288-91. 10.1302/0301-620X.85B2.13211.View ArticleGoogle Scholar
- Khosla S: The OPG/RANKL/RANK system. Endocrinology. 2001, 142: 5050-5055. 10.1210/en.142.12.5050.View ArticlePubMedGoogle Scholar
- Chambers TJ, Owens JM, Hattersley G, Jat PS, Noble MD: Generation of osteoclast-inductive and osteoclastogenic cell-lines form the H-2K(B)TSA58 transgenic mouse. PNAS. 1993, 90: 5578-82.View ArticlePubMedPubMed CentralGoogle Scholar
- Suda T, Udagawa N, Nakamura I, Miyaura C, Takahashi N: Modulation of osteoclast differentiation by local factors. Bone. 1995, 17 (2): S87-S91. 10.1016/8756-3282(95)00185-G.View ArticleGoogle Scholar
- Simonet WS, Lacey DL, Dunstan CR, Kelley M, Chang MS, Luthy R, Nguyen HQ, Wooden S, Bennett L, Boone T, Shimamoto G, DeRose M, Elliott R, Colombero A, Tan HL, Trail G, Sullivan J, Davy E, Bucay N, Renshaw , Gegg L, Hughes TM, Hill D, Pattison W, Campbell P, Sander S, Van G, Tarpley J, Derby P, Lee R, Boyle WJ: Osteoprotegerin: A novel secreted protein involved in the regulation of bone density. CELL. 1997, 89 (2): 309-319. 10.1016/S0092-8674(00)80209-3.View ArticlePubMedGoogle Scholar
- Yasuda H, Shima N, Nakagawa N, Yamaguchi K, Kinosaki M, Mochizuki S, Tomoyasu A, Yano K, Goto M, Murakami A, Tsuda E, Morinaga T, Higashio K, Udagawa N, Takahashi N, Suda T: Osteoclast differentiation factor is a ligand for osteoprotegerin osteoclastogenesis-inhibitory factor and is identical to TRANCE/RANKL. PNAS. 1998, 95 (7): 3597-3602. 10.1073/pnas.95.7.3597.View ArticlePubMedPubMed CentralGoogle Scholar
- Fazzalari NL, Kuliwaba JS, Atkins GJ, Forwood MR, Findlay DM: The ratio of messenger RNA levels of receptor activator of nuclear kappaB ligand to osteoprotegerin correlates with bone remodeling indices in normal human cancellous bone but not in osteoarthritis. J Bone Min Res. 2001, 16: 1015-27. 10.1359/jbmr.2001.16.6.1015.View ArticleGoogle Scholar
- Giuliani N, Bataille R, Mancini C, Lazzaretti M, Barille S: Myeloma cells induce imbalance in the osteoprotegerin/osteoprotegerin ligand system in the human bone marrow environment. Blood. 2001, 98: 3527-33. 10.1182/blood.V98.13.3527.View ArticlePubMedGoogle Scholar
- Ikeda T, Utsuyama M, Hirokawa K: Expression profiles of receptor activator of nuclear factor kappaB ligand, receptor activator of nuclear factor kappaB, and osteoprotegerin messenger RNA in aged and ovariectomized rat bones. J Bone Min Res. 2001, 16: 1416-25. 10.1359/jbmr.2001.16.8.1416.View ArticleGoogle Scholar
- Evans CE, Galasko CSB, Ward C: Effect of donor age on the growth in vitro of cells obtained from human trabecular bone. J Orthop Res. 1990, 8 (2): 234-237. 10.1002/jor.1100080212.View ArticlePubMedGoogle Scholar
- O'Brien EA, Williams JHH, Marshall MJ: OPG is produced when prostaglandin synthesis is inhibited causing osteoclasts to detach from the surface of mouse parietal bone and attach to the endocranial membrane. Bone. 2001, 28 (2): 208-214. 10.1016/S8756-3282(00)00431-2.View ArticlePubMedGoogle Scholar
- Komura H, Olee T, Kuhn K, Quach J, Brinson DC, Shikhman A, Valbracht J, Creighton-Achermann L, Lotz M: The osteoprotegerin/receptor activator of nuclear factor ka-paB ligand system in cartilage. Arthritis & Rheumatism. 2001, 44: 2768-76. 10.1002/1529-0131(200112)44:12<2768::AID-ART464>3.0.CO;2-I.View ArticleGoogle Scholar
- Dodds RA, Ali N, Pead MJ, Lanyon LE: Early loading-related changes in the activity of glucose 6-phosphate dehydrogenase and alkaline phosphatase in osteocytes and periosteal osteoblasts in rat fibulae in vivo. J Bone Min Res. 1993, 8: 261-7.View ArticleGoogle Scholar
- Hofbauer LC, Khosla S, Dunstan CR, Lacey DL, Boyle WJ, Riggs BL: The roles of osteoprotegerin and osteoprotegerin ligand in the paracrine regulation of bone resorption. J Bone Min Res. 2000, 15: 2-12. 10.1359/jbmr.2000.15.1.2.View ArticleGoogle Scholar
- Crisafulli A, Altavilla D, Squadrito G, Romeo A, Adamo EB, Marini R, Inferrera Marini H, Bitto A, D'Anna R, Corrado F, Bartolone S, Frisina N, Squadrito F: Effects of the phytoestrogen genistein on the circulating soluble receptor activator of nuclear factor kappa B ligand-osteoprotegerin system in early postmenopausal women. Journal of Clinical Endocrinology and Metabolism. 2004, 89: 188-192. 10.1210/jc.2003-030891.View ArticlePubMedGoogle Scholar
- Crotti TN, Smith MD, Weedon H, Capone M, Holding C, Findlay DM, Haynes DR: Osteoprotegerin (OPG) and RANKL expression in tissues near bone in diseases of pathological bone loss: A comparison of rheumatoid arthritis, prosthetic joint failure and periodontal disease. J Bone Min Res. 2001, 16: S227-S227.Google Scholar
- Mandelin J, Li TF, Lijestrom M, Hanemaaijer R, Santavirta S, Konttinen YT: Imbalance of RANKL/RANK/OPG system in interface tissue in loosening of total hip replacement. J Bone joint Surg. 2003, 85-B: 1196-1201. 10.1302/0301-620X.85B8.13311.View ArticleGoogle Scholar
- Crotti TN, Smith MD, Findlay DM, Zreiqat H, Ahern MJ, Weedon H, Hatzinilolous G, Capone M, Holding C, Haynes DR: Factors regulating osteoclast formation in human tissues adjacent to peri-implant bone loss: expression of receptor activator NF kappa β, RANK ligand and osteoprotegerin. Biomaterials. 2004, 25 (4): 565-73. 10.1016/S0142-9612(03)00556-8.View ArticlePubMedGoogle Scholar
- Gehrke T, Sers C, Morawietz L, Fernahl G, Neidel J, Frommelt L, Krenn V: Receptor activation of nuclear kappa B ligand is expressed in resident and inflammatory cells in aseptic and septic prosthesis loosening. Scand J Rheumatol. 2003, 32 (5): 287-4. 10.1080/03009740310003929.View ArticlePubMedGoogle Scholar
- Kaku M, Uoshima K, Yanashita Y, Miura H: Investigation of periodontal ligament reaction upon excessive occlusal load – osteopontin induction among periodontal ligament cells. J Periodontal Res. 2005, 40: 59-66. 10.1111/j.1600-0765.2004.00773.x.View ArticlePubMedGoogle Scholar
- Tsuji K, Uno K, Zhang GX, Tamura M: Periodontal ligament cells under intermittent stress regulate mRNA expression of osteoprotegerin and tissue inhibitor of matrix metalloprotease-1 and -2. J Bone Min Res. 2004, 22 (2): 94-103. 10.1007/s00774-003-0456-0.View ArticleGoogle Scholar
- Rubin J, Murphy TC, Fan X, Goldschmidt M, Taylor WR: Activation of extracellular signal-regulated kinase is involved in mechanical strain inhibition of RANKL expression in bone stromal cells. J Bone Min Res. 2002, 17 (8): 1452-60. 10.1359/jbmr.2002.17.8.1452.View ArticleGoogle Scholar
- MacQuarrie RA, Chen YF, Coles C, Anderson GI: Wear-particle-induced osteoclast osteolysis : The role of particulates and mechanical strain. J Biomed Mater Res. 2004, 69B: 104-112. 10.1002/jbm.b.20031.View ArticleGoogle Scholar
- Trofimov S, Pantsulaia I, Kobyliansky E, Livshits G: Circulating levels of receptor activator of nuclear factor-kappa B ligand/osteoprotegerin/macrophage-colony stimulating factor in a presumably healthy human population. Eur J Endocrinol. 2004, 150: 305-311. 10.1530/eje.0.1500305.View ArticlePubMedGoogle Scholar
- Pulsatelli L, Dolzani P, Silvestri T, Caraceni P, Facchini A, Ravaglia G, Salvarani C, Meliconi R, Mariani E: Soluble receptor activator of nuclear factor-kappa B ligand (sRANKL)/osteoprotegerin balance in ageing and age-associated diseases. Biogerentology. 2004, 5: 119-127. 10.1023/B:BGEN.0000025075.04136.ec.View ArticleGoogle Scholar
- Franck H, Meurer T, Hofbauer LC: Evaluation of bone mineral density, hormones, biochemical markers of bone metabolism, and osteoprotegerin serum levels in patients with Ankylosing spondylitis. J Rheumatol. 2004, 31: 2236-41.PubMedGoogle Scholar
- Abrahamsen B, Hjelmborg J, Kostenuik P, Stilgren LS, Kyvik K, Adamu S, Brixen K, Langdahl BL: Circulating amounts of osteoprotegerin and RANK ligand: Genetic influence and relationship with BMD assessed in female twins. Bone. 2005, 36: 727-35. 10.1016/j.bone.2004.12.015.View ArticlePubMedGoogle Scholar
- Cao JJ, Wronski T, Iwaniec U, Phleger L, Kurimoto P, Boudignon B, Halloran BP: Aging increases stromal/osteoblastic cell-induced osteoclastogenesis and alters the osteoclast precursor pool in the mouse. J Bone Min Res. 2005, 20: 1659-68. 10.1359/JBMR.050503.View ArticleGoogle Scholar
- Abdallah BM, Stilgren LS, Nissen N, Kassem M, Jorgensen HRI, Abrahamsen B: Increased RANKL/OPG mRNA ratio in iliac bone biopsies from women with hip fractures. Calcified Tissue Int. 2005, 76: 90-97. 10.1007/s00223-004-0074-4.View ArticleGoogle Scholar
- Tsangari H, Findlay DM, Kuliwaba JS, Atkins GJ, Fazzalari NL: Increased expression of IL-6 and RANK mRNA in human trabecular bone from fragility fracture of the femoral neck. Bone. 2004, 35: 334-42. 10.1016/j.bone.2004.02.006.View ArticlePubMedGoogle Scholar
- Schett G, Kiechl S, Redlich K, Oberhollenzer F, Weger S, Egger G, Mayr A, Jocher J, Xu QB, Pietschmann P, Teitelbaum S, Smolen J, Willeit J: Soluble RANKL and risk of nontraumatic fracture. JAMA. 2004, 291: 1108-13. 10.1001/jama.291.9.1108.View ArticlePubMedGoogle Scholar
- Wu H, Khanna D, Park G, Gersuk V, Nepom GT, Wong WK, Paulus HE, Tsao BP: Interaction between RANKL and HLA-DRBI genotypes may contribute to younger age at onset of seropositive rheumatoid arthritis in an inception cohort. Arthritis and Rheum. 2004, 50: 3092-3103.View ArticleGoogle Scholar
- Atkins RM, Langkamer VG, Perry MJ, Elson CJ, Collins CMP: Bone-membrane interface in aseptic loosening of total joint arthroplasties. J Arthroplast. 1997, 12 (4): 461-4. 10.1016/S0883-5403(97)90203-5.View ArticleGoogle Scholar
- Raisz LG, Trummel CL, Holick MF, DeLuca HF: 1,25-dihydroxycholecalciferol: a potent stimulator of bone resorption in tissue culture. Science. 1972, 175: 768-9.View ArticlePubMedGoogle Scholar
- Evans CE, Mylchreest S, Mee A, Berry JA, Andrew : Hydrostatic Pressure Upregulates Vitamin D3 Synthesis By Macrophages in vitro. Proceedings of International Conference on Progress in Bone and Mineral Research, Vienna,. 2003Google Scholar
- Kido S, Inoue D, Hiura K, Javier W, Ito Y, Matsumoto T: Expression of RANK is dependent upon differentiation into the macrophage/osteoclast lineage: Induction by 1 alpha, 25-hydroxyvitamin D3 and TPA in a human myelomonocytic cell line, HL60. Bone. 2003, 32 (6): 621-29. 10.1016/S8756-3282(03)00049-8.View ArticlePubMedGoogle Scholar
- Rubin J, Biskobing , Fan X, Rubin C, McLeod K, Taylor WR: Pressure regulates osteoclast formation and MCSF expression in marrow cultures. J Cellular Physiol. 1997, 170: 81-7. 10.1002/(SICI)1097-4652(199701)170:1<81::AID-JCP9>3.0.CO;2-H.View ArticleGoogle Scholar
- The pre-publication history for this paper can be accessed here:http://www.biomedcentral.com/1471-2474/7/21/prepub
This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.